On Tuesday, New Gold, Inc. (NYSEMKT:NGD)’s shares declined -3.18%, and closed at $3.65, after a gold mining corporation, declared that it will host its Annual and Special Meeting of Shareholders on Wednesday, April 29, 2015. New Gold has filed its 2014 audited financial statements, administration’s discussion and analysis (MD&A), and administration information circular, and these documents are accessible on the corporation’s website at www.newgold.com. Shareholders may request a hard copy of the complete audited financial statements and 2015 meeting materials free of charge by calling toll free 1-888-315-9715, or by emailing your request to [email protected].
The Annual and Special Meeting will start on Wednesday, April 29, 2015 at 4:00 p.m. Eastern time and will be held at St. Andrew’s Club & Conference Centre, 150 King Street West, 27th Floor, Toronto, Ontario, Canada.
New Gold Inc., a gold mining corporation, engages in the attainment, exploration, development, and operation of mineral properties. It primarily explores for gold, silver, and copper deposits. The corporation’s operating properties comprise a 100% interest in the New Afton gold-copper mine in British Columbia, Canada; the Mesquite gold mine in California; the Peak gold-copper mines in New South Wales, Australia; and the Cerro San Pedro gold-silver mine in the state of San Luis Potosí, Mexico.
ImmunoCellular Therapeutics, Ltd. (NYSEMKT:IMUC)’s shares dropped -3.12%, and settled at $0.47, hitting new 52-week low of $0.46, during the last trading session on Tuesday, as a clinical-stage biotechnology corporation, on March 19, declared the establishment of an contract with PharmaCell B.V. to provide contract manufacturing services for the European production of ICT-107, a dendritic cell-based cancer immunotherapy in development as a potential treatment for glioblastoma (GBM). This contract with PharmaCell, a leading European contract manufacturing organization focuses on the production of human cell therapy products, and is designed to enable ImmunoCellular to access phase 3 supplies of ICT-107, manufactured with ImmunoCellular’s commercial-ready production process. ImmunoCellular intends to initiate a Phase 3 registrational program for ICT-107 in the US and in Europe in 2015.
ImmunoCellular plans to initiate a technology transfer process from its North American manufacturer to harmonize the EU and US methods of production of ICT-107 for the planned phase 3 registration trial. The technology transfer process is anticipated to start as soon as practicable.
ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology corporation, develops immune-based therapies for the treatment of brain and ovarian cancers. Its lead product candidate comprises ICT-107, a dendritic cell (DC) vaccine that accomplished Phase II testing trials for the treatment of glioblastoma multiforme (GBM).
At the end of Tuesday’s trade, Sunstone Hotel Investors Inc. (NYSE:SHO)’s shares dipped -3.04%, and closed at $16.56, as a real estate investment trust, declared that it has reached a new senior unsecured credit facility. Under the Facility, the Corporation’s total accessible capacity raises from $150 million to $400 million. Facility pricing ranges from 155 to 230 basis points over LIBOR, depending on the Corporation’s leverage, and represents a decline in pricing of about 30 to 60 basis points. The Facility term is four years, expiring in April 2019, with an option to extend for an additional one year subject to satisfaction of certain customary conditions. The Facility also comprises an accordion option which allows the Corporation to request additional lender commitments for up to a total capacity of $800 million. The Corporation presently has no outstanding balance on the $400 million revolving credit facility.
The Corporation’s $400 million unsecured credit facility is led jointly by Wells Fargo Securities LLC, Merrill Lynch, Pierce, Fenner & Smith, Incorporated, and J.P. Morgan Securities, LLC. Wells Fargo Bank, National Association serves as the Administrative Agent, Bank of America, N.A. and JP Morgan Chase Bank, N.A. serve as the Syndication Agents and Citibank, N.A., PNC Bank, National Association and U.S. Bank, National Association serve as the Documentation Agents.
Sunstone Hotel Investors, Inc. operates as a real estate investment trust. The firm engages in the attainment, ownership, asset administration, renovation, and sale of luxury, upper upscale, and upscale full-service hotels in the United States. Its portfolio also comprises mid-scale hotels. Sunstone Hotel Investors was founded in 1995 and is based in Aliso Viejo, California.
FuelCell Energy Inc. (NASDAQ:FCEL), ended its Tuesday’s trading session with -3.01% loss, and closed at $1.29, as a global leader in the design, manufacture, operation and service of ultra-clean, efficient and reliable fuel cell power plants, declared the execution of a definitive term sheet with existing customer Pepperidge Farm, Incorporated to install a 1.4 megawatt Direct FuelCell(R) (DFC(R)) power plant at its bakery in Bloomfield, Connecticut. FuelCell Energy will manufacture, install and service the power plant with work on the project commencing right away. Pepperidge Farm will pay for power as it is produced under a power purchase contract (PPA). This new power plant will supplement the existing DFC power plant that was installed at the bakery in 2008 and has been generating savings for Pepperidge Farm and carbon reductions ever since. The contract also comprises the multi-year extension of the service contract for the existing DFC power plant. FuelCell Energy is developing this project and anticipates to close on permanent financing on or before the commercial operation date of the power plant, with commissioning predictable by the end of 2015.
“The addition of this low-emission fuel cell power plant to complement our existing fuel cell installation further enhances our sustainability profile, reflecting our strong commitment to the environmental welfare of the communities in which Pepperidge Farm and our parent, Campbell Soup, operate,” said Harry Pettit, Manager of Systems and Infrastructure Engineering, Pepperidge Farm, Incorporated. “We look forward to broadening and deepening our partnership with FuelCell Energy and ongoing to benefit from the efficient and reliable on-site power and heat its fuel cell power plants provide.”
“Pepperidge Farm is a great example of a customer that has practiced noteworthy savings in power costs and dramatically reduced pollutant and carbon emissions, while improving energy security and power reliability,” said Chip Bottone, Chief Executive Officer, FuelCell Energy, Inc. “Our ultra-clean and affordable power plants add value for food and beverage processors such as Pepperidge Farm and repeat orders like this validate our solutions and customer service commitment.”
FuelCell Energy, Inc., together its auxiliaries, designs, manufactures, sells, installs, operates, and services stationary fuel cell power plants for distributed power generation. The corporation is also involved in the development, design, production, and sale of fuel cell products under the Direct FuelCell name. Its power plants electrochemically produce electricity and heat using various fuels, counting natural gas, methanol, diesel, biogas, coal gas, coal mine methane, and propane.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
